Medical education needs to be redesigned so that it is an equally shared responsibility of clinicians and physician-scientists, with greatly enhanced opportunities for student-faculty bonding. Traditional departments and divisions must be restructured to provide more thoughtful and effective support for academic clinicians and physician-scientists. Existing infrastructure should be improved so that in exchange for the commitment of time and effort for teaching, the faculty members receive tangible services from their institutions (e.g., information technology that actually saves time, state-of-the art teaching aids that are user friendly, streamlined administrative oversight to avoid duplicate submissions to regulatory offices, more helpful grant management and accounting).

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC524237PMC
http://dx.doi.org/10.1172/JCI23408DOI Listing

Publication Analysis

Top Keywords

clinicians physician-scientists
8
lost gold
4
gold decline
4
decline academic
4
academic mission
4
mission medical
4
medical schools
4
schools medical
4
medical education
4
education redesigned
4

Similar Publications

There has been considerable discussion of how best to address racial and ethnic disparities in health outcomes, both globally and specifically in the United States. Increasing diversity among future clinicians and physician-scientists has been identified as a key strategy for addressing and correcting health disparities among underrepresented populations. Increasingly, medical schools, the institutions that train clinicians, have embraced the practice of holistic review for evaluating applicants and virtually all medical schools have reported contributing to a diverse physician workforce as an important aspect of their educational mission.

View Article and Find Full Text PDF

Background: There is a significant lag in integrating ethnically diverse healthcare trainees as clinician scientists. Although this gap is acknowledged, it is mostly focused physician scientists with a marked lag in dental scientists and the other healthcare fields such as the physician assistant program. We report on the outcome of three cohorts of underserved and economically disadvantaged trainees from a National Institute of Health Heart and Lung Blood Institute R25 summer training program with participants from four Rutgers Health Science schools.

View Article and Find Full Text PDF

Background: Almost 40% of the Nobel-Prize-winning discoveries in medicine are made by physician-scientists, who are a driving force in the evolving medical, academic and research landscape. However, their training has few defined milestones. To be effective clinicians, educators and researchers, they need to maintain and hone skills, often via continuous professional development (CPD) activities covering different domains.

View Article and Find Full Text PDF

From MGUS to multiple myeloma: Unraveling the unknown of precursor states.

Blood Rev

November 2024

Myeloma Institute, Sylvester Comprehensive Cancer Center, Division of Myeloma, University of Miami, Miami, FL, United States of America. Electronic address:

Article Synopsis
  • In the 1960s, Dr. Waldenström identified "benign monoclonal gammopathy," a condition in asymptomatic patients with detectable monoclonal protein, which later led to the recognition of its potential progression to multiple myeloma by Dr. Kyle in 1978, coining the term MGUS.
  • Following this, Drs. Kyle and Greipp in 1980 proposed the term "smoldering multiple myeloma" (SMM) for asymptomatic cases that didn't fit existing definitions, establishing criteria based on plasma cell percentage and serum protein levels.
  • Current research focuses on advanced technologies (like whole genome sequencing) to enhance understanding of monoclonal gammopathy and improve individualized
View Article and Find Full Text PDF

Flow cytometric analysis of the murine placenta to evaluate nanoparticle platforms during pregnancy.

Placenta

August 2024

Department of Bioengineering, University of Pennsylvania, Philadelphia, PA, United States; Penn Institute for RNA Innovation, Perelman School of Medicine, Philadelphia, PA, United States; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States; Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States; Cardiovascular Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States; Institute for Regenerative Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States; Center for Precision Engineering for Health, University of Pennsylvania, Philadelphia, PA, United States. Electronic address:

Clinically approved therapeutics for obstetric conditions are extremely limited, with over 80% of drugs lacking appropriate labeling information for pregnant individuals. The pathology for many of these obstetric conditions can be linked to the placenta, necessitating the development of therapeutic platforms for selective drug delivery to the placenta. When evaluating therapeutics for placental delivery, literature has focused on ex vivo delivery to human placental cells and tissue, which can be difficult to source for non-clinical researchers.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!